NVCRVSSLS• 28 Days (Normalized)
NVCR vs SLS (NovoCure Limited vs SELLAS Life Sciences Group Inc.)
Showing Closing Date Range from Aug, 20 to Sep, 17, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
NVCR Performance $16.72
-5.91%
NovoCure Limited
Normalized Baseline0.00%
SLS Performance $11.53
-13.96%
SELLAS Life Sciences Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin NVCR LEADS
+8.05%
NVCR outperforming by 8.05%
NVCRSLS
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
NVCR SLS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | NVCR Price | NVCR Gain (%) | SLS Price | SLS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 17, 2026 | $16.72 | -5.91% | $11.53 | -13.96% | +8.05% |
| Sep 16, 2026 | $16.22 | -8.72% | $11.66 | -12.99% | +4.27% |
| Sep 15, 2026 | $16.15 | -9.12% | $11.29 | -15.75% | +6.63% |
| Sep 14, 2026 | $16.22 | -8.72% | $11.73 | -12.46% | +3.74% |
| Sep 11, 2026 | $15.51 | -12.72% | $11.55 | -13.81% | +1.09% |
| Sep 10, 2026 | $15.35 | -13.62% | $13.49 | +0.67% | -14.29% |
| Sep 09, 2026 | $15.63 | -12.04% | $13.95 | +4.10% | -16.14% |
| Sep 08, 2026 | $16.85 | -5.18% | $13.96 | +4.18% | -9.36% |
| Sep 04, 2026 | $17.94 | +0.96% | $13.86 | +3.43% | -2.47% |
| Sep 03, 2026 | $17.64 | -0.73% | $13.70 | +2.24% | -2.97% |
| Sep 02, 2026 | $17.83 | +0.34% | $14.16 | +5.67% | -5.33% |
| Sep 01, 2026 | $17.38 | -2.19% | $13.22 | -1.34% | -0.85% |
| Aug 31, 2026 | $17.65 | -0.68% | $13.34 | -0.45% | -0.23% |
| Aug 28, 2026 | $17.82 | +0.28% | $13.21 | -1.42% | +1.70% |
| Aug 27, 2026 | $17.99 | +1.24% | $15.21 | +13.51% | -12.27% |
Page 1 of 2